Clinical Trials for Obstructive Hypertrophic Cardiomyopathy

Find clinical trials for obstructive hypertrophic cardiomyopathy. Discover research opportunities and treatment options in your area.

10 Active Trials Found

Showing 10 trials on this page

Page 1 of 1

A Study to Learn More About How Well Aficamten Works in Japanese Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

NCT ID: NCT07023341

This clinical trial is studying a new medicine called aficamten to see how well it works for Japanese adults who have a heart condition called symptomatic obstructive hypertrophic cardiomyopathy (o...

Recruiting

Phase: PHASE3 Type: interventional Locations: Sendai, Miyagi, Japan, Hamamatsu, Shizuoka, Japan +23 more

A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

NCT ID: NCT07021976

This clinical trial is studying a new treatment called HRS-1893 for patients with a condition known as obstructive hypertrophic cardiomyopathy (oHCM). This heart condition causes the heart muscle t...

Recruiting

Phase: PHASE3 Type: interventional Locations: Beijing, Beijing, China

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

NCT ID: NCT05489705

This clinical trial is studying the real-world characteristics and treatment outcomes of patients with symptomatic obstructive hypertrophic cardiomyopathy (Obstructive-HCM), a condition where the h...

Recruiting

Type: observational Locations: Pittsburgh, Pennsylvania, United States, Charleston, South Carolina, United States +137 more

Efficacy of Mavacamten Combined With Radiofrequency Ablation in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

NCT ID: NCT06856265

This clinical trial is looking at the effectiveness and safety of a medication called Mavacamten when combined with a procedure known as radiofrequency ablation in patients who have a condition cal...

Not yet recruiting

Phase: NA Type: interventional

Real-world Patient Reported Outcomes Among Patients Treated With Camzyos

NCT ID: NCT06551129

This clinical trial is looking at how patients with a heart condition called obstructive hypertrophic cardiomyopathy (HCM) feel after being treated with a medication called mavacamten. The study ai...

Recruiting

Type: observational Locations: Boston, Massachusetts, United States

A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

NCT ID: NCT06146660

This clinical trial is studying the safety of a medication called mavacamten for adults in Korea who have a condition known as obstructive hypertrophic cardiomyopathy (oHCM). This is a heart condit...

Recruiting

Type: observational Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +2 more

Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

NCT ID: NCT06023186

This clinical trial is looking at how a medication called mavacamten affects blood flow in the heart muscle of patients with a condition known as obstructive hypertrophic cardiomyopathy (oHCM). The...

Recruiting

Type: observational Locations: Charlottesville, Virginia, United States

Percutaneous Endocardial Septal Radiofrequency Ablation in Obstructive Hypertrophic Cardiomyopathy

NCT ID: NCT06224621

This clinical trial is studying a procedure called Percutaneous Endocardial Septal Radiofrequency Ablation (PESA) to treat patients with obstructive hypertrophic cardiomyopathy (oHCM). This conditi...

Recruiting

Phase: NA Type: interventional Locations: Beijing, , China

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

NCT ID: NCT06368037

This clinical trial is looking at a new treatment method for patients with obstructive hypertrophic cardiomyopathy, a heart condition that can cause severe symptoms like fatigue and shortness of br...

Not yet recruiting

Phase: NA Type: interventional Locations: Shenyang, , China

An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM

NCT ID: NCT06116968

This clinical trial is studying a medication called aficamten to see how well it works and how safe it is for Chinese patients with a heart condition known as obstructive hypertrophic cardiomyopath...

Recruiting

Phase: PHASE3 Type: interventional Locations: Guangzhou, , China, Beijing, , China +11 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions